From policy to practice: Experiences from the ECHO trial following revisions of the WHO medical eligibility criteria for contraceptive use (MEC) guidance on DMPA-IM

• Main Authors: Petrus Steyn (Author), Mags Beksinska (Author), Melanie Pleaner (Author), Hui-Zhen Tam (Author), Jenni Smit (Author), Kathy Baisley (Author), Douglas Taylor (Author), Mandisa Singata-Madliki (Author), G. Justus Hofmeyr (Author), Thesla Palanee-Phillips (Author), James N. Kiarie (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: In 2017, the World Health Organization (WHO) medical eligibility criteria (MEC) for contraception category for intramuscular depot medroxyprogesterone acetate (DMPA-IM) was changed from MEC category 1 to 2 for women at high risk of HIV acquisition. We assessed the impact of communicating...